Purchase Order 75N93019P00698
Award Date 6/26/19
Potential Completion Date 7/10/19
Potential Value $99K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Derwood, MD 20855, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, MD. The contract is for $151,620.00 and covers site-directed mutagenesis, gene synthesis, and plasmid preparation services in support of COVID-19 research. The contract was awarded on a sole-source basis pursuant to FAR...
- This is a firm fixed-price purchase order contract awarded to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $50,955 contract is for subcloning, mutagenesis, and DNA preparation test services, and was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health. The contract has an ultimate completion date of January 19, 2015 and was awarded on...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The contract has a potential value of $12,265.00 and is focused on DNA preparation services. The contract was set aside for small businesses and does not appear to be associated with a larger contract vehicle. Geneimmune...
- This federal contract award is for site-directed mutagenesis services (Catalog #GI-M100) provided by Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, MD. The $9,994.40 firm fixed price contract was awarded on September 22, 2010 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). The contract has an ultimate completion date of September 30, 2010 and does not have a set-aside designation. Geneimmune Biotechnology Corp....
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to GeneUniversal Inc., a small business located in Newark, Delaware. The $99,794.60 contract is for gene synthesis services, including subcloning, site-directed mutagenesis, PCR cloning, and plasmid preparation. The contract is not set aside and was awarded on a sole source basis, as NIAID determined GeneUniversal...
- The National Institute of Allergy and Infectious Diseases awarded a $149,959.70 firm fixed-price purchase order to Geneuniversal Inc. on September 8, 2021, for gene synthesis, site-directed mutagenesis, PCR cloning, and plasmid preparation services. The contract, with an ultimate completion date of September 7, 2022, was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $249,996 firm fixed price purchase order to Gene By Gene, LTD for clinical grade whole genome sequencing services. The contract calls for Gene By Gene to deliver these sequencing services from its Houston, Texas facility between September 1, 2023 and December 31, 2023 to support NIAID's research efforts in the areas of allergy and infectious disease. No...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, is for $20,000.00 in custom gene synthesis and expression services provided by Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. While the original solicitation is not provided, the award likely...